In describing a new Phase III trial, Napo Pharmaceuticals touts its adaptive approach. Will other sponsors stoke investor interest using the anticipation surrounding adaptive trials? more...

The Canadian EDC supplier offers a true zero-footprint offering, with benefits in speed and user-friendliness. The company believes it is especially well-positioned to handle trials in different regulatory jurisdictions. more...

The founder of a SAS-based clinical data management system talks about clinical data management and standards. more...

A discussion about infrastructure for adaptive clinical trials. With process change and the right technology, Cytel‘s Jerry Schindler says, pharma could wring significant savings out of clinical development. more...

In addition to embarking on a rapid adoption of an adaptive design, the biotech company is making an unusually swift and public acknowlegment of an innovative strategy. more...

Fascinating Wall Street Journal coverage of instruments and software from Affy, Illumina.  And a note about Insightful Software tools to help sort off what comes of such equipment. more...

Kevin Keim has spent 30 years in the industry. Our interview touches on the importance of realistic training, statistical missteps and INC’s “trusted process.” more...

How to support and implement adaptive trial techniques will be the hottest topic in the industry during 2007. more...

The Cleveland Clinic chooses Steven Nissen to be interim head of cardiovascular medicine. more...

The software is available through August, 2006. more...

Analytics for clinical trials—and more. more...

A 23 percent rise in revenue for the end of 2005. more...

more...